Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin L Moore

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 8, 2018
Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent WheezeKedir N Turi, Jyoti Shankar, Larry J Anderson, et al.
Infection and Immunity|June 25, 2014
Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent mannerDaniel E Dulek, Dawn C Newcomb, Kasia Goleniewska, et al.
Nature Communications|September 23, 2016
A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaquesSujin Lee, Minh Trang Nguyen, Michael G Currier, et al.
The Journal of Allergy and Clinical Immunology|January 14, 2018
Nasopharyngeal Lactobacillus is associated with a reduced risk of childhood wheezing illnesses following acute respiratory syncytial virus infection in infancyChristian Rosas-Salazar, Meghan H Shilts, Andrey Tovchigrechko, et al.
The Journal of Infectious Diseases|December 8, 2016
Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in InfancyChristian Rosas-Salazar, Meghan H Shilts, Andrey Tovchigrechko, et al.
The Journal of General Virology|June 12, 2019
Evaluation of the role of respiratory syncytial virus surface glycoproteins F and G on viral stability and replication: implications for future vaccine designDarby M DeFord, Jenna M Nosek, Katelyn R Castiglia, et al.
Nature Communications|December 1, 2017
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoproteinDaiyin Tian, Michael B Battles, Syed M Moin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 12, 2014
Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cellsEun-Ju Ko, Young-Man Kwon, Jong Seok Lee, et al.
BMC Pulmonary Medicine|May 30, 2015
Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE)Emma K Larkin, Tebeb Gebretsadik, Martin L Moore, et al.
Nature Microbiology|July 1, 2017
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responsesSrirupa Chatterjee, Priya Luthra, Ekaterina Esaulova, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
American Journal of Respiratory and Critical Care Medicine|May 8, 2018
Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent WheezeKedir N Turi, Jyoti Shankar, Larry J Anderson, et al.
Infection and Immunity|June 25, 2014
Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent mannerDaniel E Dulek, Dawn C Newcomb, Kasia Goleniewska, et al.
Nature Communications|September 23, 2016
A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaquesSujin Lee, Minh Trang Nguyen, Michael G Currier, et al.
The Journal of Allergy and Clinical Immunology|January 14, 2018
Nasopharyngeal Lactobacillus is associated with a reduced risk of childhood wheezing illnesses following acute respiratory syncytial virus infection in infancyChristian Rosas-Salazar, Meghan H Shilts, Andrey Tovchigrechko, et al.
The Journal of Infectious Diseases|December 8, 2016
Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in InfancyChristian Rosas-Salazar, Meghan H Shilts, Andrey Tovchigrechko, et al.
The Journal of General Virology|June 12, 2019
Evaluation of the role of respiratory syncytial virus surface glycoproteins F and G on viral stability and replication: implications for future vaccine designDarby M DeFord, Jenna M Nosek, Katelyn R Castiglia, et al.
Nature Communications|December 1, 2017
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoproteinDaiyin Tian, Michael B Battles, Syed M Moin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 12, 2014
Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cellsEun-Ju Ko, Young-Man Kwon, Jong Seok Lee, et al.
BMC Pulmonary Medicine|May 30, 2015
Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE)Emma K Larkin, Tebeb Gebretsadik, Martin L Moore, et al.
Nature Microbiology|July 1, 2017
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responsesSrirupa Chatterjee, Priya Luthra, Ekaterina Esaulova, et al.
Pageof 9